Genex Pharmaceutical Inc
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin, the People's Rep… Read more
Genex Pharmaceutical Inc (GENX) - Total Assets
Latest total assets as of December 2007: $8.65 Million USD
Based on the latest financial reports, Genex Pharmaceutical Inc (GENX) holds total assets worth $8.65 Million USD as of December 2007.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Genex Pharmaceutical Inc - Total Assets Trend (2003–2007)
This chart illustrates how Genex Pharmaceutical Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Genex Pharmaceutical Inc - Asset Composition Analysis
Current Asset Composition (December 2007)
Genex Pharmaceutical Inc's total assets of $8.65 Million consist of 24.8% current assets and 75.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.0% |
| Accounts Receivable | $163.82K | 1.9% |
| Inventory | $484.84K | 5.6% |
| Property, Plant & Equipment | $196.10K | 2.3% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2007)
This chart illustrates how Genex Pharmaceutical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genex Pharmaceutical Inc's current assets represent 24.8% of total assets in 2007, a decrease from 73.6% in 2003.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2007, down from 46.4% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 26.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 5.6% of total assets.
Genex Pharmaceutical Inc Competitors by Total Assets
Key competitors of Genex Pharmaceutical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Genex Pharmaceutical Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Genex Pharmaceutical Inc generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Genex Pharmaceutical Inc generates $ 3.96 in net profit.
Genex Pharmaceutical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.62 | 0.94 | 0.58 |
| Quick Ratio | 0.48 | 0.66 | 0.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.34 Million | $ -99.36K | $ -9.57K |
Genex Pharmaceutical Inc - Advanced Valuation Insights
This section examines the relationship between Genex Pharmaceutical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.08 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 50.5% |
| Total Assets | $8.65 Million |
| Market Capitalization | $0.97 USD |
Valuation Analysis
Below Book Valuation: The market values Genex Pharmaceutical Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Genex Pharmaceutical Inc's assets grew by 50.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Genex Pharmaceutical Inc (2003–2007)
The table below shows the annual total assets of Genex Pharmaceutical Inc from 2003 to 2007.
| Year | Total Assets | Change |
|---|---|---|
| 2007-12-31 | $8.65 Million | +50.55% |
| 2006-12-31 | $5.74 Million | +29.93% |
| 2005-12-31 | $4.42 Million | +50.42% |
| 2004-12-31 | $2.94 Million | +13218.81% |
| 2003-12-31 | $22.07K | -- |